Table 3 Calculated descriptors for studied heterocyclic compounds.

From: Computer aided study on cyclic tetrapeptide based ligands as potential inhibitors of Proplasmepsin IV

 

HOMO (eV)

LUMO (eV)

EG (eV)

DM (Debye)

MW (amu)

S.E (kJ/mol)

Energy (au)

Energy (aq)

Log P

Area

Vol

Pol

OVA

PSA

HBD

HBA

F1

− 6.89

− 2.93

3.96

4.63

536.541

− 103.76

− 1.866.63

− 1.866.67

− 0.67

507.16

509.98

81.81

1.64

118.928

4

11

F2

− 6.57

− 2.45

4.12

9.96

549.540

− 79.12

− 1920.83

− 1920.87

− 1.57

529.75

518.06

82.43

1.70

148.86

4

12

F3

− 6.80

− 2.51

4.29

5.54

563.56

− 97.69

− 1960.13

− 1960.17

− 1.29

546.85

536.28

83.86

1.71

157.80

4

12

F4

− 6.50

− 3.02

3.48

10.12

591.62

− 116.73

− 2034.91

− 2034.96

− 0.67

578.24

568.46

86.67

1.74

163.26

3

11

F5

− 5.86

− 3.35

2.51

12.13

566.63

− 62.36

− 2228.93

− 2228.95

0.37

551.64

541.73

84.73

1.72

109.46

3

11

F6

− 6.90

− 2.44

4.46

4.50

522.51

− 99.54

− 1827.33

− 1827.37

− 0.99

510.86

494.75

80.45

1.69

141.720

4

11

F7

− 6.88

− 3.37

3.51

12.84

550.52

− 86.48

− 1940.69

− 1940.72

− 0.92

518.51

513.07

82.17

1.67

142.26

4

11

F8

− 6.92

− 2.89

4.03

7.58

564.55

− 67.43

− 1980.01

− 1980.04

− 0.64

542.05

533.23

83.68

1.70

148.12

4

11

F9

− 6.43

− 2.71

3.72

7.77

563.61

− 72.25

− 1925.38

− 1925.41

− 0.40

553.12

551.93

85.27

1.70

136.04

3

11

F10

− 6.73

− 2.96

3.77

5.49

538.58

− 62.08

− 2150.26

− 2150.29

− 0.16

500.71

503.61

81.34

1.64

112.914

4

11